Search

Author/Creator Mealy, Maureen A

1. Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning. (October 2020)

Authors:
Sotirchos, Elias S; Filippatou, Angeliki; Fitzgerald, Kathryn C; Salama, Sara; Pardo, Santiago; Wang, Jiangxia; Ogbuokiri, Esther; Cowley, Norah J; Pellegrini, Nicole; Murphy, Olwen C; Mealy, Maureen A; Prince, Jerry L; Levy, Michael; Calabresi, Peter A; Saidha, Shiv
Journal:
Multiple sclerosis
Issue:
Volume 26:Number 11(2020)
Page Start:
1360
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders. (November 2018)

Authors:
Mealy, Maureen A; Kim, Su-Hyun; Schmidt, Felix; López, Reydmar; Jimenez Arango, Jorge A; Paul, Friedemann; Wingerchuk, Dean M; Greenberg, Benjamin M; Kim, Ho Jin; Levy, Michael
Journal:
Multiple sclerosis
Issue:
Volume 24:Number 13(2018)
Page Start:
1737
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging. (March 2016)

Authors:
Pekcevik, Yeliz; Mitchell, Charles H; Mealy, Maureen A; Orman, Gunes; Lee, In H; Newsome, Scott D; Thompson, Carol B; Pardo, Carlos A; Calabresi, Peter A; Levy, Michael; Izbudak, Izlem
Journal:
Multiple sclerosis
Issue:
Volume 22:Number 3(2016)
Page Start:
302
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Evidence of subclinical quantitative retinal layer abnormalities in AQP4-IgG seropositive NMOSD. (October 2021)

Authors:
Filippatou, Angeliki G; Vasileiou, Eleni S; He, Yufan; Fitzgerald, Kathryn C; Kalaitzidis, Grigorios; Lambe, Jeffrey; Mealy, Maureen A; Levy, Michael; Liu, Yihao; Prince, Jerry L; Mowry, Ellen M; Saidha, Shiv; Calabresi, Peter A; Sotirchos, Elias S
Journal:
Multiple sclerosis
Issue:
Volume 27:Number 11(2021)
Page Start:
1738
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Long-term efficacy and safety of inebilizumab in neuromyelitis optica spectrum disorder: Analysis of aquaporin-4–immunoglobulin G–seropositive participants taking inebilizumab for ⩾4 years in the N-MOmentum trial. (May 2022)

Authors:
Rensel, Mary; Zabeti, Aram; Mealy, Maureen A; Cimbora, Daniel; She, Dewei; Drappa, Jorn; Katz, Eliezer
Journal:
Multiple sclerosis
Issue:
Volume 28:Number 6(2022)
Page Start:
925
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗